Phase IIb/III Chemoprevention Trial of Celecoxib to Prevent Recurrence of Superficial Bladder Cancer.

Trial Profile

Phase IIb/III Chemoprevention Trial of Celecoxib to Prevent Recurrence of Superficial Bladder Cancer.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 12 Feb 2013

At a glance

  • Drugs Celecoxib (Primary)
  • Indications Bladder cancer
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 26 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 26 Apr 2009 Results have been presented at the American Urological Association Annual Meeting 2009.
    • 26 Apr 2009 Primary endpoint 'Time to disease recurrence' has not been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top